ClinicalTrials.gg
CompletedNCT05571254SEEDUpdated Mar 23, 2023

The Management of Transient Loss of Consciousness and Suspected Syncope in European Emergency Departments

An observational study in Syncope, sponsored by NHS Lothian. Completed at 57 sites in 18 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-03-23.

Sponsored by NHS Lothian · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
952
Ages
18 Years and older
Sex
All
01

Study summary

Prospective multi centre cohort study examining the clinical presentation, diagnostic tests, and management of adult Emergency Department (ED) patients presenting with Transient Loss of Consciousness (TLOC) either undifferentiated or thought to be of syncopal origin.

Read the detailed description

Syncope is a common ED problem. The three underlying causes are reflex (simple faint), orthostatic hypotension (blood pressure fall on standing) and cardiac disease (structural heart disease or cardiac dysrhythmia). Diagnosis is difficult and is not apparent in \~50% of patients after assessment. For the first time, European Society of Cardiology (ESC) guidelines incorporating ED management of patients presenting with TLOC, either undifferentiated or thought to be of syncopal origin, have been produced.

However, very little is currently known about the use of diagnostic algorithms and management of this patient group in EDs across Europe. As a result, the application of guidelines and the management of TLOC by European Society of Emergency Medicine (EUSEM) members in different countries and hospitals, cannot yet be recommended for use in settings other than those where they have been successfully validated.

This study aims to describe the prevalence, clinical presentation, current assessment, management strategies and ESC risk categories of patients presenting with TLOC (undifferentiated or thought to be of syncopal origin) to the ED, and will provide data to help identify the gaps in our knowledge and practice, and areas where further research and development work is required to fully implement European Society of Cardiology (ESC) guidelines within European EDs.

02

Conditions studied

  • Syncope

Keywords

  • syncope
  • transient loss of consciousness
  • emergency department
03

In context

Syncope

201 studies on the registry are indexed under Syncope; 36 are open to participants now.

This study's enrollment of 952 is above the median of 250 across 84 observational studies indexed under Syncope.

Browse Syncope studies →

Lead sponsor

NHS Lothian is the lead sponsor of 53 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults 18 years of age and older presenting to the ED over a two-week period with TLOC, either undifferentiated or thought to be of syncopal origin.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adult patients (≥18 years old) assessed in the ED with TLOC thought to be of syncopal origin.

Exclusion criteria

Exclusion Criteria:

  • Inability to consent
  • Patient in custody or prison
  • Aged \<18 years
  • TLOC thought to be due to neurological seizure (e.g., epilepsy/alcohol or drug withdrawal) or trauma
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
952 participants (actual)
Patient registry
No

Interventions

  • OtherData collection

    All patients will have a focussed Case Report Form completed collecting routine data describing the prevalence, clinical presentation, assessment, management and ESC risk category of patients, at the time or shortly after the patients ED attendance.

06

What researchers measure

Primary outcomes

  1. Participant age

    Participant age

    Time frame: Admission

  2. Participant gender

    Participant gender

    Time frame: Admission

  3. Mode of arrival

    Mode of arrival

    Time frame: Admission

  4. Referral source

    Referral source

    Time frame: Admission

  5. Presence of any European Society of Cardiology (ESC) syncope high-risk history features

    Which European Society of Cardiology syncope high-risk history features are present

    Time frame: Admission

  6. ESC high-risk 'past medical history' features

    Which European Society of Cardiology syncope high-risk 'past medical history' features are present

    Time frame: Admission

  7. Other medical comorbidities

    Other medical comorbidities

    Time frame: Admission

  8. Rockwood Clinical Frailty Scale score

    Rockwood Clinical Frailty Scale is a well validated score ranging from 1 (Very Fit) to 9 (Terminally Ill) with defined descriptions for each category.

    Time frame: Admission

  9. ESC high risk 'physical examination' factors

    ESC high risk 'physical examination' factors

    Time frame: Admission

  10. Blood pressure (BP) on admission

    First Blood pressure (BP) measure in the Emergency Department in mmHg

    Time frame: Admission

  11. Pulse rate on admission

    First pulse rate measured in the Emergency Department in beats per minute

    Time frame: Admission

  12. Lying/standing systolic BP difference on admission

    First lying/standing systolic BP difference measured in the Emergency Department in mmHg

    Time frame: Admission

  13. Number of participants with abnormal Electrocardiogram (ECG) readings

    Number of participants with abnormal ECG readings

    Time frame: Admission

  14. Troponin levels

    Troponin levels

    Time frame: Admission

  15. D-dimer levels

    D-dimer levels

    Time frame: Admission

  16. Copeptin levels

    Copeptin levels

    Time frame: Admission

  17. Natriuretic peptides levels

    Natriuretic peptides levels

    Time frame: Admission

  18. ED clinician diagnosis

    ED clinician diagnosis - descriptive

    Time frame: Admission

  19. Patient destination

    Descriptive options: Admitted to Observation/Clinical Decision Unit/Same Day Emergency Care unit/hospital floor with telemetry monitoring/hospital floor with no telemetry monitoring. Discharged to outpatient follow up/family doctor/General Practitioner care/home with no follow up

    Time frame: Admission

  20. Reason(s) for admission

    Reason(s) for admission

    Time frame: Admission

  21. Whether driving and occupation advice given

    Whether driving and occupation advice given

    Time frame: Admission

  22. Status at discharge from hospital

    Status at discharge from hospital

    Time frame: 30 days

  23. Length of hospital stay in days

    Length of hospital stay in days

    Time frame: 30 days

  24. Hospital discharge diagnosis

    Hospital discharge diagnosis

    Time frame: 30 days

07

Study locations

57 sites
  • Regional Hospital Durres
    Durres, Albania
  • Regional Hospital Centre "Xh. Kongoli" Elbasan
    Elbasan, Albania
  • Spitali "Petro Nako" Sarandra
    Sarande, Albania
  • Regional Hospital Shkoder
    Shkodra, Albania
  • University Hospital Centre "Mother Theresa" Tirana
    Tirana, Albania
  • Allgemeines Krankenhaus der Stadt Wien/ Universitätskliniken
    Vienna, Austria
  • Klinik Donaustadt
    Vienna, Austria
  • AZ Sint Jan Brugge
    Brugge, Belgium
  • AZ Alma Eeklo
    Eeklo, Belgium
  • Ghent University Hospital
    Ghent, Belgium
  • Heilig Hartziekenhuis Lier
    Lier, Belgium
  • University Hospital Hradec Králové
    Králová, Czechia
  • University Hospital Královské Vinohrady
    Praha, Czechia
  • Regionshospitalet Gødstrup
    Herning, Denmark
  • Nordsjællands Hospital
    Hillerød, Denmark
  • Regionshospitalet Randers
    Randers, Denmark
  • Sjællands Universitetshospital
    Roskilde, Denmark
  • Regionshospitalet Midt
    Vildbjerg, Denmark
  • Kanta-Häme Central Hospital
    Helsinki, Finland
  • CHU Besançon
    Besançon, France
  • CHU Caen
    Caen, France
  • CHU Clermond-Ferrand
    Clermont-Ferrand, France
  • Medipole
    Lyon, France
  • CHU Tours
    Tours, France
  • University General Hospital ATTIKON
    Athens, Greece
  • General Hospital Venizeleio
    Heraklion, Greece
  • AHEPA Univesrity General Hospital of Thessaloniki
    Thessaloníki, Greece
  • Semmelweis University Department of Emergency Medicine
    Budapest, Hungary
  • ED Azienda Ospedaliera Universitaria di Bologna (Sant'Orsola Hospital)
    Bologna, Italy
  • ED Azienda Ospedaliera-universitaria di Catania (San Marco Hospital)
    Catania, Italy
  • ED Azienda USL Toscana Centro, Firenze (San Giovanni di Dio Hospital)
    Firenze, Italy
  • Azienda Ospedaliera di Perugia (Santa Maria Della Misericordia Hospital)
    Perugia, Italy
  • ED Azienda Ospedaliera-Universitaria integrata (Borgo Trento Hospital)
    Verona, Italy
  • Mater Dei Hospital
    Birkirkara, Malta
  • Gozo General Hospital
    Victoria, Malta
  • St. Olav's University Hospital
    Trondheim, Norway
  • Wroclaw University Hospital
    Wrocław, Poland
  • Cluj Napoca County Emergency Clinical Hospital
    Cluj-Napoca, Romania
  • Saint Spiridon County Hospital
    Iaşi, Romania
  • Emergency Center Belgrade, Clinical Centre Belgade
    Belgrad, Serbia
  • Clinical Centre of Niš
    Niš, Serbia
  • Emergency Department Zaječar, Health Center Zaječar
    Zaječar, Serbia
  • Hospital Dr. Balmis
    Alicante, Spain
  • Hospital clinic Barcelona
    Barcelona, Spain
  • Hospital de Terrassa
    Barcelona, Spain
  • Hospital Universitari de Bellvitge
    Barcelona, Spain
  • Hospital Universitari de Vic
    Barcelona, Spain
  • Gazi University Medical Faculty Department of Emergency Medicine
    Ankara, Turkey
  • Medical Science University Ankara Education and Research Hospital Department of Emergency Medicine
    Ankara, Turkey
  • Karamanoglu Mehmetbey University Karaman Education and Research Hospital Department of Emergency Medicine
    Karaman, Turkey
  • Necmettin Erbakan University Medical Faculty Department of Emergency Medicine
    Konya, Turkey
  • Medical Science University Sanliurfa Mehmet Akif Inan Education and Research Hospital Department of Emergency Medicine
    Şanlıurfa, Turkey
  • Royal Infirmary of Edinburgh
    Edinburgh, Midlothian EH16 4SA, United Kingdom
  • University Hospital Coventry & Warwickshire
    Coventry, United Kingdom
  • Victoria Hospital
    Kirkcaldy, United Kingdom
  • St Johns Hospital, Livingston
    Livingston, United Kingdom
  • Royal Preston Hospital
    Preston, United Kingdom
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 23, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05571254
Lead sponsor
NHS Lothian
Responsible party
Sponsor
First posted
Oct 7, 2022
Start date
Sep 12, 2022
Primary completion
Dec 2, 2022
Completion
Dec 2, 2022
Last update
Mar 23, 2023

Study contacts

Matt Reed
study chair · University of Edinburgh

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion